Logo image of JT

JIANPU TECHNOLOGY INC-SP ADR (JT) Stock Fundamental Analysis

NYSE:JT - US47738D3098 - ADR

0.7799 USD
+0.06 (+7.78%)
Last: 2/20/2024, 8:04:00 PM
0.76 USD
-0.02 (-2.55%)
After Hours: 2/13/2024, 8:04:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to JT. JT was compared to 54 industry peers in the Consumer Finance industry. JT may be in some trouble as it scores bad on both profitability and health. JT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year JT has reported negative net income.
In the past 5 years JT always reported negative net income.
JT had a negative operating cash flow in each of the past 5 years.
JT Yearly Net Income VS EBIT VS OCF VS FCFJT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -100M -200M -300M -400M

1.2 Ratios

JT's Return On Assets of -5.01% is on the low side compared to the rest of the industry. JT is outperformed by 77.36% of its industry peers.
The Return On Equity of JT (-11.42%) is worse than 75.47% of its industry peers.
Industry RankSector Rank
ROA -5.01%
ROE -11.42%
ROIC N/A
ROA(3y)-18.01%
ROA(5y)-17.59%
ROE(3y)-37.96%
ROE(5y)-33.36%
ROIC(3y)N/A
ROIC(5y)N/A
JT Yearly ROA, ROE, ROICJT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 500 1K

1.3 Margins

JT's Gross Margin of 24.17% is on the low side compared to the rest of the industry. JT is outperformed by 62.26% of its industry peers.
JT's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for JT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-38.14%
GM growth 5Y-24.93%
JT Yearly Profit, Operating, Gross MarginsJT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 50 -50 -100

More info and screens

3

2. Health

2.1 Basic Checks

JT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JT remains at a similar level compared to 1 year ago.
The debt/assets ratio for JT is higher compared to a year ago.
JT Yearly Shares OutstandingJT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M
JT Yearly Total Debt VS Total AssetsJT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B 2B

2.2 Solvency

JT has an Altman-Z score of -0.67. This is a bad value and indicates that JT is not financially healthy and even has some risk of bankruptcy.
JT has a Altman-Z score of -0.67. This is in the lower half of the industry: JT underperforms 71.70% of its industry peers.
JT has a Debt/Equity ratio of 0.60. This is a neutral value indicating JT is somewhat dependend on debt financing.
The Debt to Equity ratio of JT (0.60) is better than 75.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Altman-Z -0.67
ROIC/WACCN/A
WACC6.34%
JT Yearly LT Debt VS Equity VS FCFJT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 500M 1B 1.5B

2.3 Liquidity

JT has a Current Ratio of 1.67. This is a normal value and indicates that JT is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.67, JT is doing good in the industry, outperforming 64.15% of the companies in the same industry.
JT has a Quick Ratio of 1.67. This is a normal value and indicates that JT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.67, JT is in the better half of the industry, outperforming 64.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.67
JT Yearly Current Assets VS Current LiabilitesJT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B 2B

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 77.76% over the past year.
JT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.33%.
The Revenue has been decreasing by -7.30% on average over the past years.
EPS 1Y (TTM)77.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.43%
Revenue 1Y (TTM)-10.33%
Revenue growth 3Y-11.66%
Revenue growth 5Y-7.3%
Sales Q2Q%-4.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JT Yearly Revenue VS EstimatesJT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B
JT Yearly EPS VS EstimatesJT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 -2 -4 -6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

JT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JT Price Earnings VS Forward Price EarningsJT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JT Per share dataJT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for JT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JIANPU TECHNOLOGY INC-SP ADR

NYSE:JT (2/20/2024, 8:04:00 PM)

After market: 0.76 -0.02 (-2.55%)

0.7799

+0.06 (+7.78%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)11-30 2023-11-30/bmo
Earnings (Next)03-19 2024-03-19/bmo
Inst Owners0.41%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.55M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 0.28
P/tB 0.3
EV/EBITDA N/A
EPS(TTM)-0.32
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS7.06
BVpS2.76
TBVpS2.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.01%
ROE -11.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.17%
FCFM N/A
ROA(3y)-18.01%
ROA(5y)-17.59%
ROE(3y)-37.96%
ROE(5y)-33.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-38.14%
GM growth 5Y-24.93%
F-ScoreN/A
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.67
Quick Ratio 1.67
Altman-Z -0.67
F-ScoreN/A
WACC6.34%
ROIC/WACCN/A
Cap/Depr(3y)30.34%
Cap/Depr(5y)60.27%
Cap/Sales(3y)0.43%
Cap/Sales(5y)0.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.33%
Revenue growth 3Y-11.66%
Revenue growth 5Y-7.3%
Sales Q2Q%-4.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y68.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y47.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.52%
OCF growth 3YN/A
OCF growth 5YN/A